Cryoport, Inc.'s revenue was $176m in fiscal 2025, up 12.4% on the year before. Since fiscal 2011 ($475,504) it has grown at a compound 52.6% a year. Over the last twelve months it was $186m.
Revenue history
US$ millions unless shown otherwise.
Fiscal years, plus the last twelve months (LTM) when newer.
Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.
Where the revenue comes from
Fiscal year to December 31, 2025
Segments
Line of business
Revenue
Share
YoY
Reportable Segment Aggregation Before Other Operating
$176M
100.0%
▲ 12.4%
↳ Life Sciences Services (part of Reportable Segment Aggregation Before Other Operating)
$101M
57.3%
▲ 18.4%
↳ Life Sciences Products (part of Reportable Segment Aggregation Before Other Operating)
$75.1M
42.7%
▲ 5.2%
Services$96.5M
Products$79.7M
Products and services
Line of business
Revenue
Share
YoY
Services
$96.5M
54.8%
▲ 17.6%
↳ Biologistics Solutions (part of Services)
$78.1M
81.0%
▲ 16.6%
↳ Biostorage Bioservices (part of Services)
$18.4M
19.0%
▲ 22.2%
Products
$79.7M
45.2%
▲ 6.6%
Americas$131M
EMEA$25.1M
Asia Pacific$19.8M
Geography
Region
Revenue
Share
YoY
Americas
$131M
74.5%
▲ 15.6%
EMEA
$25.1M
14.3%
▼ 7.0%
Asia Pacific
$19.8M
11.2%
▲ 22.1%
From Cryoport, Inc.'s 10-K filed March 5, 2026, as tagged in the filing.
View filing. Indented rows are part of the
line above; their share is of that line. In the bars, the
faint bar behind is the year before.
Revenue against peers
Life Sciences Tools & Services: the closest covered companies by revenue. Last twelve months.
Figures from Cryoport, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026.
How we read and check them: methodology and data sources.
Not investment advice. Back to Cryoport, Inc.
